Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PAPPA2
is a metalloproteinase which cleaves insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5, and its role in pregnancy and postnatal growth is primarily studied. Using exclusion mapping, we reported a subcongenic (26-P) rat where a 0.71-Mbp region containing the pregnancy-associated plasma protein a2 (
Pappa2
) allele of salt-insensitive
Brown
Norway (BN) was introgressed into Dahl saltsensitive (SS) genetic background, resulting in the reduction of salt sensitivity.
Pappa2
was differentially expressed in the adult kidney of 26-P and SS rats. Here, the expression and cellular localization of
Pappa2
in embryonic and postnatal kidneys of 26-P and SS rats were examined.
Pappa2
mRNA expression was 5-fold higher in the embryonic kidney (day 20.5) of the 26-P rat compared with the SS rat.
Pappa2
mRNA expression progressively increased with the development of kidney, reaching a peak at postnatal day 5 before trending downward in subsequent stages of development in both strains. At all tested time points,
Pappa2
remained higher in the 26-P compared with the SS rat kidney. Immunohistochemistry studies localized
PAPPA2
in the ureteric bud (UB) and distal part of S-shaped body.
PAPPA2
was colocalized with IGFBP-5 in the UB and Na
+
/K
+
/2Cl
-
cotransporter-stained tubules, respectively. Future studies are needed to determine the role of
Pappa2
in kidney development and mechanistic pathways involved in this process.
...
PMID:Temporal Expression and Cellular Localization of PAPPA2 in the Developing Kidney of Rat. 3198 54